Key Points
- Christopher Joyce sold 18,013 shares of Alignment Healthcare on April 1 at an average price of $17.79 for proceeds of $320,451, reducing his stake by 5.57% to 305,451 shares (≈$5.43M).
- Alignment Healthcare reported Q4 EPS of ($0.05) vs. consensus ($0.15) and revenue of $1.01B (up 44.4% year‑over‑year), though the company still posted a slightly negative net margin and return on equity.
- Analysts remain generally positive with a consensus rating of "Moderate Buy" and a $24.56 average price target, backed by upgrades from firms including TD Cowen, KeyCorp and JPMorgan.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Christopher Joyce sold 18,013 shares of Alignment Healthcare stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $17.79, for a total value of $320,451.27. Following the completion of the sale, the insider directly owned 305,451 shares of the company's stock, valued at approximately $5,433,973.29. The trade was a 5.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Alignment Healthcare Price Performance
ALHC opened at $18.76 on Friday. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. The company's 50-day simple moving average is $19.56 and its two-hundred day simple moving average is $18.86. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The stock has a market capitalization of $3.83 billion, a P/E ratio of -1,874.13, a P/E/G ratio of 2.61 and a beta of 1.20.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.10. The company had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The firm's quarterly revenue was up 44.4% on a year-over-year basis. During the same quarter last year, the company posted ($0.16) earnings per share. As a group, analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.
Institutional Investors Weigh In On Alignment Healthcare
Several hedge funds have recently modified their holdings of the business. Teacher Retirement System of Texas boosted its position in Alignment Healthcare by 85.8% during the third quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company's stock valued at $1,794,000 after purchasing an additional 47,472 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of Alignment Healthcare in the third quarter worth $3,499,000. Hudson Bay Capital Management LP acquired a new stake in Alignment Healthcare during the 3rd quarter worth about $4,581,000. Cinctive Capital Management LP acquired a new stake in shares of Alignment Healthcare during the third quarter worth about $3,814,000. Finally, Inspire Investing LLC acquired a new stake in Alignment Healthcare during the 3rd quarter valued at approximately $1,129,000. Hedge funds and other institutional investors own 86.19% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the company. TD Cowen boosted their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a report on Friday, January 16th. KeyCorp reissued an "overweight" rating and set a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. Finally, Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Alignment Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $24.56.
Read Our Latest Report on ALHC
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
